Fig. 3From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trialThe impacts of grade II–IV aGVHD (a, b) and donor-recipient ABO compatibility (c, d) on 5-year DFS between MSD and AD in one hundred eleven children with acute leukemiaBack to article page